| 165.04 -0.3 (-0.18%) | 06-12 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 196.2 |
1-year : | 229.16 |
| Resists | First : | 167.97 |
Second : | 196.2 |
| Pivot price | 160.15 |
|||
| Supports | First : | 158.66 |
Second : | 152.91 |
| MAs | MA(5) : | 162.6 |
MA(20) : | 160.15 |
| MA(100) : | 169 |
MA(250) : | 160.53 |
|
| MACD | MACD : | -0.5 |
Signal : | -1.6 |
| %K %D | K(14,3) : | 85.2  |
D(3) : | 81.6 |
| RSI | RSI(14): 58.2 |
|||
| 52-week | High : | 183.89 | Low : | 138.31 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ BCpC ] has closed below upper band by 6.2%. Bollinger Bands are 22.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 168.37 - 169.2 | 169.2 - 169.87 |
| Low: | 161.84 - 162.97 | 162.97 - 163.89 |
| Close: | 163.47 - 165.17 | 165.17 - 166.55 |
Balchem Corporation specializes in the creation, production, and distribution of high-performance specialty ingredients and solutions, catering to diverse sectors including human and animal nutrition, food and pharmaceuticals, medical device sterilization, agricultural plant health, and various industrial applications, operating both domestically and globally. The company organizes its operations into three primary divisions: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment primarily serves the food and beverage industry with essential ingredients. Its extensive product portfolio encompasses spray-dried and emulsified powders, extrusion and agglomeration technologies, specialized lipid blends, liquid flavor delivery solutions, various bases for juices, dairy, chocolate, and cereals, alongside ice cream bases and variegates. Additionally, this segment provides microencapsulation technologies for diverse uses, in addition to human-grade choline nutrients and chelated mineral amino acid products vital for health and wellness. The Animal Nutrition & Health segment delivers microencapsulated products designed to boost the health and milk yield of ruminant animals, while also supplying nutrient supplements. It also leverages chelation technology to improve nutrient absorption across a wide range of production and companion animal species, and offers choline chloride, a key nutrient for the health of monogastric animals. The Specialty Products segment is a supplier of ethylene oxide (EtO), primarily utilized for sterilization within the healthcare sector, including single-use canisters for sterilizing reusable medical devices. Furthermore, it markets propylene oxide, a fumigant effective in controlling insects, microbial spoilage, and reducing bacterial and mold contamination in a variety of food products such as nuts (shelled and processed), spices, cacao beans, cocoa powder, and dried fruits like raisins, figs, and prunes. The segment also provides chelated minerals tailored for high-value agricultural crops. Balchem distributes its offerings through a combination of its direct sales force, independent distributors, and dedicated sales agents. Established in 1967, Balchem Corporation maintains its headquarters in New Hampton, New York.
Sat, 13 Jun 2026
Understanding the Setup: (BCPC) and Scalable Risk - Stock Traders Daily
Wed, 27 May 2026
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026 - GlobeNewswire
Wed, 06 May 2026
Here’s Why Investors Favored Balchem Corp. (BCPC) - Yahoo Finance
Mon, 04 May 2026
Balchem Corporation (NASDAQ:BCPC) Q1 2026 Earnings Call Transcript - Insider Monkey
Thu, 30 Apr 2026
Balchem Corporation 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:BCPC) 2026-04-30 - Seeking Alpha
Thu, 30 Apr 2026
Is Balchem (BCPC) Overvalued After Q1 2026 Earnings? EPS $1.25 I - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Chemicals - Specialty
|
|
| Shares Out | 32 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 0.4 (%) |
| Held by Institutions | 93.6 (%) |
| Shares Short | 416 (K) |
| Shares Short P.Month | 345 (K) |
| EPS | 4.86 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 40 |
| Profit Margin | 14.9 % |
| Operating Margin | 20.8 % |
| Return on Assets (ttm) | 8 % |
| Return on Equity (ttm) | 12.6 % |
| Qtrly Rev. Growth | 8.1 % |
| Gross Profit (p.s.) | 11.93 |
| Sales Per Share | 32.99 |
| EBITDA (p.s.) | 8.13 |
| Qtrly Earnings Growth | 10.6 % |
| Operating Cash Flow | 220 (M) |
| Levered Free Cash Flow | 138 (M) |
| PE Ratio | 33.88 |
| PEG Ratio | 3.7 |
| Price to Book value | 4.12 |
| Price to Sales | 5 |
| Price to Cash Flow | 24.08 |
| Dividend | 0.95 |
| Forward Dividend | 0 |
| Dividend Yield | 0.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|